Combined Actions and Interactions of Chemicals in Mixtures

with combinations of environmental chemicals. Environ Health Perspect, 105
Suppl 3, 615-618.
Ashby J and Styles JA (1980). Carcinogenic synergism and its reflection in vitro.
Br Med Bull, 36, 63-70.
Ashford JR (1981). General models for the joint action of drugs. Biometrics, 37,
457-474.
Ashford JR and Cobby JM (1974). A system of models for the action of drugs
applied singly or jointly to biological organisms. Biometrics, 30, 11-31.
ATBC cancer prevention study group (1994). The effect of vitamin E and betacarotene
on the incidence of lung cancer and other cancers in male smokers. The
Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med,
330, 1029-1035.
At-Guideline C.0.1 (2000). Exposure Limit Values for Substances and Materials.
Danish Working Environment Authority, Copenhagen, October 2000 (in Danish).
ATSDR (2002). Guidance manual for the assessment of joint toxic action of
chemical mixtures. Draft for public comment February 2002. U.S. Department of
Health and Human Services, Public Health Service, Agency of Toxic Substances
and Disease Registry, Division of Toxicology, Atlanta, U.S.A.
Autrup H and Dragsted L (1987). Overview of tumor promoters & test systems to
identify promoters. Nord, 25, Nordic Council of Ministers, Copenhagen.
Barch DH, Rundhaugen LM, Stoner GD, Pillay NS and Rosche WA. (1996).
Structure-function relationships of the dietary anticarcinogen ellagic acid.
Carcinogenesis, 17, 265-269.
Barton JC and Conrad ME (1978). Effects of ethanol on the absorption and retention
of lead. Proc Soc Exp Biol Med, 159, 213-218.
Basketter DA and Allenby CF (1991). Studies of the quenching phenomenon in
delayed contact hypersenitivity reaction. Contact Dermatitis, 25, 160-171.
Becher H, Jockel KH, Timm J, Wichmann HE and Drescher K (1991). Smoking
cessation and nonsmoking intervals: effect of different smoking patterns on lung
cancer risk. Cancer Causes Control, 2, 381-387.
Berenbaum MC (1981). Criteria for analyzing interactions between biologically
active agents. Adv Cancer Res, 35, 269-335.
Berenbaum MC (1985). The expected effect of a combination of agents: the
general solution. J Theoret Biol, 114, 413-431.
Berenbaum MC (1989). What is synergy? Pharmacol Rev, 41, 93-141.
Berenblum I and Shubik P (1947). The role of croton oil applications, associated
with a single painting of a carcinogen, in tumour induction of the mouse skin. Exp
Carcinogen, 59, 379-382.
Berenblum I (1941a). The mechanism of carcinogenesis. Cancer Res, 1, 807-814.
134